Sanofi India Limited [SANOFI] vs Sanofi Consumer [SANOFICONR] Detailed Stock Comparison
TLDR: Quick Comparison Summary
Based on 20 vital metrics comparison: Sanofi India Limited wins in 10 metrics, Sanofi Consumer Healthcare Inc. wins in 9 metrics, with 0 ties. Sanofi India Limited appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Sanofi India Limited | Sanofi Consumer Healthcare Inc. | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 24.31 | 43.91 | Sanofi India Limited |
| Price-to-Book Ratio | 10.59 | 27.44 | Sanofi India Limited |
| Debt-to-Equity Ratio | 2.38 | 6.46 | Sanofi India Limited |
| PEG Ratio | -0.97 | 34.17 | Sanofi Consumer Healthcare Inc. |
| EV/EBITDA | 16.08 | 33.08 | Sanofi India Limited |
| Profit Margin (TTM) | 17.78% | 27.33% | Sanofi Consumer Healthcare Inc. |
| Operating Margin (TTM) | 19.32% | 34.42% | Sanofi Consumer Healthcare Inc. |
| EBITDA Margin (TTM) | 19.32% | 34.42% | Sanofi Consumer Healthcare Inc. |
| Return on Equity | 40.59% | 73.09% | Sanofi Consumer Healthcare Inc. |
| Return on Assets (TTM) | 19.81% | 37.99% | Sanofi Consumer Healthcare Inc. |
| Free Cash Flow (TTM) | $4.13B | $1.67B | Sanofi India Limited |
| Dividend Yield | 4.60% | 1.08% | Sanofi India Limited |
| 1-Year Return | -49.23% | -8.68% | Sanofi Consumer Healthcare Inc. |
| Price-to-Sales Ratio (TTM) | 4.32 | 12.01 | Sanofi India Limited |
| Enterprise Value | $78.16B | $102.22B | Sanofi Consumer Healthcare Inc. |
| EV/Revenue Ratio | 4.25 | 11.64 | Sanofi India Limited |
| Gross Profit Margin (TTM) | 50.43% | 72.79% | Sanofi Consumer Healthcare Inc. |
| Revenue per Share (TTM) | $798 | $381 | Sanofi India Limited |
| Earnings per Share (Diluted) | $141.75 | $104.19 | Sanofi India Limited |
| Beta (Stock Volatility) | 0.18 | N/A | N/A |
Sanofi India Limited vs Sanofi Consumer Healthcare Inc. Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Sanofi India Limited | 3.84% | 2.46% | 0.71% | -5.74% | -22.80% | -20.92% |
| Sanofi Consumer Healthcare Inc. | 2.24% | 0.01% | -3.05% | 10.56% | 2.80% | 3.48% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Sanofi India Limited | -49.23% | -54.97% | -58.99% | -25.65% | 55.45% | 103.00% |
| Sanofi Consumer Healthcare Inc. | -8.68% | -5.84% | -5.84% | -5.84% | -5.84% | -5.84% |
Performance & Financial Health Analysis: Sanofi India Limited vs Sanofi Consumer Healthcare Inc.
| Metric | SANOFI | SANOFICONR |
|---|---|---|
| Market Information | ||
| Market Cap | ₹79.35B | ₹105.86B |
| Market Cap Category | Mid cap | Mid cap |
| 10 Day Avg. Volume | 46,430 | 5,238 |
| 90 Day Avg. Volume | 36,764 | 11,327 |
| Last Close | ₹3,240.70 | ₹4,720.10 |
| 52 Week Range | ₹3,054.00 - ₹6,410.00 | ₹3,975.00 - ₹5,894.50 |
| % from 52W High | -49.44% | -19.92% |
| All-Time High | ₹10,524.95 (Jun 10, 2024) | ₹5,894.50 (Jun 30, 2025) |
| % from All-Time High | -69.21% | -19.92% |
| Growth Metrics | ||
| Quarterly Revenue Growth | -0.19% | 0.33% |
| Quarterly Earnings Growth | -0.33% | 0.50% |
| Financial Health | ||
| Profit Margin (TTM) | 0.18% | 0.27% |
| Operating Margin (TTM) | 0.19% | 0.34% |
| Return on Equity (TTM) | 0.41% | 0.73% |
| Debt to Equity (MRQ) | 2.38 | 6.46 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | ₹325.31 | ₹166.71 |
| Cash per Share (MRQ) | ₹114.15 | ₹162.89 |
| Operating Cash Flow (TTM) | ₹4.38B | ₹1.75B |
| Levered Free Cash Flow (TTM) | ₹3.58B | ₹1.27B |
| Dividends | ||
| Last 12-Month Dividend Yield | 4.60% | 1.08% |
| Last 12-Month Dividend | ₹192.00 | ₹55.00 |
Valuation & Enterprise Metrics Analysis: Sanofi India Limited vs Sanofi Consumer Healthcare Inc.
| Metric | SANOFI (Apr 24, 2026) | SANOFICONR (Apr 24, 2026) |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 24.31 | 43.91 |
| Forward P/E | 19.43 | 34.17 |
| PEG Ratio | -0.97 | 34.17 |
| Price to Sales (TTM) | 4.32 | 12.01 |
| Price to Book (MRQ) | 10.59 | 27.44 |
| Market Capitalization | ||
| Market Capitalization | ₹79.35B | ₹105.86B |
| Enterprise Value | ₹78.16B | ₹102.22B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 4.25 | 11.64 |
| Enterprise to EBITDA | 16.08 | 33.08 |
| Risk & Other Metrics | ||
| Beta | 0.18 | N/A |
| Book Value per Share (MRQ) | ₹325.31 | ₹166.71 |
Financial Statements Comparison: Sanofi India Limited vs Sanofi Consumer Healthcare Inc.
Financial Metrics
Loading Financial Charts...
Revenue
Operating Margin
Profit Margin
Long Term Debt
Income Flow Analysis
Financial Statements Comparison
Income Statement
| Metric | SANOFI (2025) | SANOFICONR (2025) |
|---|---|---|
| Revenue/Sales | 18.23B | 8.78B |
| Cost of Goods Sold | 9.06B | 2.30B |
| COGS % of Revenue | 49.7% | 26.2% |
| Gross Profit | 9.18B | 6.48B |
| Gross Margin | 50.3% | 73.8% |
| Research & Development | N/A | N/A |
| Operating Income (EBIT) | 4.54B | 2.97B |
| Operating Margin | 24.9% | 33.8% |
| EBITDA | 5.10B | 3.27B |
| EBITDA Margin | 28.0% | 37.3% |
| Pre-Tax Income | 4.45B | 3.20B |
| Pre-Tax Income % of Revenue | 24.4% | 36.5% |
| Income Tax | 1.18B | 802.00M |
| Income Tax % of Revenue | 6.5% | 9.1% |
| Net Income (Profit) | 3.27B | 2.40B |
| Profit Margin | 17.9% | 27.3% |
Balance Sheet & Liquidity Metrics
| Metric | SANOFI (2025) | SANOFICONR (2025) |
|---|---|---|
| Cash & Equivalents | 2.63B | 3.75B |
| Total Current Assets | 8.01B | 4.94B |
| Total Current Assets % of Revenue | 43.9% | 56.3% |
| Total Current Liabilities | 4.91B | 1.28B |
| Total Current Liabilities % of Revenue | 26.9% | 14.6% |
| Long-Term Debt | 137.00M | 171.00M |
| Long-Term Debt % of Revenue | 0.8% | 1.9% |
| Total Shareholders Equity | 7.49B | 3.84B |
| Retained Earnings | 3.32B | N/A |
| Retained Earnings % of Revenue | 18.2% | 0.0% |
| Property, Plant & Equipment | 3.03B | 351.00M |
Cash Flow Statement Comparison
| Metric | SANOFI (2025) | SANOFICONR (2025) |
|---|---|---|
| Operating Cash Flow | 7.22B | 2.38B |
| Operating Cash Flow % of Revenue | 39.6% | 27.1% |
| Capital Expenditures | -253.00M | -76.00M |
| Free Cash Flow | 4.13B | 1.67B |
| FCF Margin | 22.6% | 19.0% |
| Debt Repayment | N/A | N/A |
| Common Stock Repurchase | N/A | N/A |
Short Interest & Institutional Ownership Analysis
| Metric | SANOFI | SANOFICONR |
|---|---|---|
| Shares Short | N/A | N/A |
| Short Ratio | N/A | N/A |
| Short % of Float | N/A | N/A |
| Shares Outstanding | 23.03M | 23.03M |
| Float Shares | 9.07M | 6.57M |
| % Held by Insiders | 60.61% | 71.46% |
| % Held by Institutions | 24.40% | 17.51% |
| % Held by Public | 14.99% | 11.03% |
Dividend Analysis & Yield Comparison: Sanofi India Limited vs Sanofi Consumer Healthcare Inc.
| Metric | SANOFI | SANOFICONR |
|---|---|---|
| Last 12-Month Dividend | ₹192.00 | ₹55.00 |
| Last 12-Month Dividend Yield | 4.60% | 1.08% |
| 3-Year Avg Annual Dividend | ₹245.33 | ₹18.33 |
| 3-Year Avg Dividend Yield | 2.49% | 1.11% |
| 3-Year Total Dividends | ₹736.00 | ₹55.00 |
| Ex-Dividend Date | Nov 07, 2025 | Apr 17, 2025 |